Sapienza Università di Roma, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari - Reumatologia, Roma, Italy.
Translational Immunology Section, Office of Science and Technology, National Institute of Arthritis, Musculoskeletal and Skin Diseases, Bethesda, MD, USA.
Sci Immunol. 2020 May 8;5(47). doi: 10.1126/sciimmunol.abc5367.
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
JAK 激酶抑制剂正被作为一种治疗严重 COVID-19 患者细胞因子风暴的方法进行研究。